93 results
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
J.P. Morgan Healthcare Conference Agios Pharmaceuticals Brian Goff, Chief Executive Officer January 10, 2024 Exhibit 99.2
Forward-looking statements … of complications increasing as patients age Poor Quality of Life Adult patients with NTDT may have similar or worse Healthcare Related QoL compared with patients
8-K
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The full text of the press release is furnished as Exhibit 99.1 … to this Current Report on Form 8-K and is incorporated herein by reference. The slides to be presented by the Company at the 42nd Annual J.P. Morgan Healthcare
8-K
EX-99.1
kwldp4nx
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.1
0stdcd9 v5li
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
kw8q4lpbq83gjk
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
z231n04 flg
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.1
0brm l0mk
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
engcbf92ofa
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
EX-99.1
gc7ki ad2m
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
EX-99.1
s3kr 6fdp
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
EX-99.1
eva27lau b58
4 Aug 22
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
7:14am